Financhill
Buy
53

APPF Quote, Financials, Valuation and Earnings

Last price:
$233.67
Seasonality move :
3.61%
Day range:
$230.63 - $235.30
52-week range:
$190.24 - $326.04
Dividend yield:
0%
P/E ratio:
41.75x
P/S ratio:
9.36x
P/B ratio:
16.75x
Volume:
200.3K
Avg. volume:
268.7K
1-year change:
-11.57%
Market cap:
$8.4B
Revenue:
$794.2M
EPS (TTM):
$5.57

APPF Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for AppFolio, Inc. shares anticipate an average target of $317.20, ranging from a low estimate of $270.00 to a high estimate of $350.00. This average target implies a growth of 36.39% compared to the current stock price of $232.57.

Consensus Price Target

$317.20

Highest Price Target

$350.00

Lowest Price Target

$270.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 2 3 3

Hold 3 0 0

Sell 0 0 0
Consensus Hold Buy Buy

APPF Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 1.16% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 3.96% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 6.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock